|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Heart, Lung, and Blood Institute (NHLBI) |
|---|---|
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00106470 |
Purpose
The purpose of this study is to examine genetic factors that influence the development of chronic obstructive pulmonary disease (COPD) in Hispanics, a minority group at high risk for the disease.
| Condition |
|---|
|
Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based Time Perspective: Cross-Sectional |
| Official Title: | Genetic Epidemiology of COPD in Costa Rica |
Serum
| Estimated Enrollment: | 900 |
| Study Start Date: | February 2005 |
| Estimated Study Completion Date: | January 2010 |
DESIGN NARRATIVE:
This study will concentrate on a genetically isolated Hispanic population with a high prevalence of COPD living in the Central Valley of Costa Rica. Nine hundred individuals from descendants of the Costa Rican Central Valley founder population will be enrolled. To identify regions of the genome that are likely to contain genetic determinants of COPD-related phenotypes in this population, the study will collect phenotypic and genotypic data on 30 large families with a history of moderate to severe COPD that have multiple individuals affected with smoking-related airflow obstruction. A genome scan will be conducted on these individuals using short-tandem repeat (STR) markers. Linkage analysis will be performed on 6 COPD-related phenotypes, which will include the following: 1) chronic bronchitis; 2) airflow obstruction; 3) FEV1; 4) FEV1/FVC; 5) bronchodilator responsiveness; and 6) total serum IgE. Within genomic regions demonstrating linkage to COPD-related phenotypes in the genome scan, narrowly spaced STR markers will be genotyped and tested for linkage between these markers and COPD-related phenotypes. Within selected genomic regions, the association will be tested between single nucleotide polymorphisms (SNPs) in candidate genes and COPD-related phenotypes. By enrolling a large number of participants of a genetically isolated population and utilizing a family-based study design, this study should be able to address an important yet unstudied issue: the genetic influences on the expression of the COPD phenotype in Hispanics.
Eligibility| Ages Eligible for Study: | 21 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Families of individuals with physician-diagnosed COPD and smoking-related airflow obstruction who are younger than 71 years.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Manuel E. Soto-Quiros, MD, PhD | 011 506 258 0749 | msotoq@hnn.sa.cr |
| Costa Rica | |
| Hospital Nacional de Niños | Recruiting |
| San José, Costa Rica | |
| Contact: Manuel E. Soto-Quiros, MD, PhD 011-506-258-0749 msotoq@hnn.sa.cr | |
| Study Chair: | Juan C. Celedon, MD, DrPH | Brigham and Women's Hospital |
More Information
| Responsible Party: | Juan C. Celedon, MD, DrPH (Principal Investigator), Brigham and Women's Hospital, Harvard Medical School |
| ClinicalTrials.gov Identifier: | NCT00106470 History of Changes |
| Other Study ID Numbers: | 1289, R01 HL73373 |
| Study First Received: | March 24, 2005 |
| Last Updated: | July 14, 2009 |
| Health Authority: | United States: Federal Government |
|
Chronic Obstructive Pulmonary Disease |
|
Chronic Disease Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive |
Lung Diseases, Obstructive Disease Attributes Pathologic Processes Respiratory Tract Diseases |